Product Information
LITHOSTAT 250 MG TABLET is a brand product labeled by Mission Pharmacal Company, priced at $6.6632 per EA under NDC 00178050001. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
250 mg/1
Manufacturer
Mission Pharmacal CompanyNDC
00178050001
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETOHYDROXAMIC ACIDApproval Type
New Drug (NDA)
FDA Application
NDA018749On Market Since
5/31/1983
Pharmacological Classes
Price Statistics
The NADAC for LITHOSTAT 250 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has risen 7.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6632 per EA |
|---|---|
| All-time high | $7.1601 (Feb 11, 2026) |
| All-time low | $6.2283 (Apr 17, 2024) |
| 52-week high | $7.1601 |
| 52-week low | $6.5717 |
| Median price | $6.6729 |
| Average price | $6.7297 |
| Largest weekly change | -8.1% (Feb 18, 2026) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the acetohydroxamic acid market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LITHOSTAT 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LITHOSTAT 250 MG TABLET, manufactured by Mission Pharmacal Company, is $6.6632 per EA (NDC 00178050001), effective Jun 24, 2026.
How has the price of LITHOSTAT 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for LITHOSTAT 250 MG TABLET has risen 7.0%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LITHOSTAT 250 MG TABLET?
Since Apr 17, 2024, the NADAC for LITHOSTAT 250 MG TABLET has ranged from a low of $6.2283 (Apr 17, 2024) to a high of $7.1601 (Feb 11, 2026), with a median of $6.6729 per EA.
Are there cheaper alternatives to LITHOSTAT 250 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LITHOSTAT 250 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures LITHOSTAT 250 MG TABLET?
LITHOSTAT 250 MG TABLET (NDC 00178050001) is labeled by Mission Pharmacal Company, and CMS classifies it as a brand product.
Related Drugs
Same classification